The global market for Orally Dissolving Tablets (ODT) Excipient was estimated to be worth US$ 16650 million in 2023 and is forecast to a readjusted size of US$ 21290 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Orally Dissolving Tablets (ODT) Excipient - Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Dissolving Tablets (ODT) Excipient, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Orally Dissolving Tablets (ODT) Excipient by region & country, by Type, and by Application.

The Orally Dissolving Tablets (ODT) Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Dissolving Tablets (ODT) Excipient.

Market Segmentation

Scope of Orally Dissolving Tablets (ODT) Excipient - Market Report

Report Metric	Details
Report Name	Orally Dissolving Tablets (ODT) Excipient - Market
Forecasted market size in 2030	US$ 21290 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	Binders Glidents Diluents Disintegrants Sweeteners Others
Segment by Application	Anti-Psychotics Drug Anti-Epileptics Drug Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Orally Dissolving Tablets (ODT) Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Orally Dissolving Tablets (ODT) Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Orally Dissolving Tablets (ODT) Excipient in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Orally Dissolving Tablets (ODT) Excipient - Market size in 2030?

Ans: The Orally Dissolving Tablets (ODT) Excipient - Market size in 2030 will be US$ 21290 million.

Who are the main players in the Orally Dissolving Tablets (ODT) Excipient - Market report?

Ans: The main players in the Orally Dissolving Tablets (ODT) Excipient - Market are BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical

What are the Application segmentation covered in the Orally Dissolving Tablets (ODT) Excipient - Market report?

Ans: The Applications covered in the Orally Dissolving Tablets (ODT) Excipient - Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

What are the Type segmentation covered in the Orally Dissolving Tablets (ODT) Excipient - Market report?

Ans: The Types covered in the Orally Dissolving Tablets (ODT) Excipient - Market report are Binders, Glidents, Diluents, Disintegrants, Sweeteners, Others

1 Market Overview

1.1 Orally Dissolving Tablets (ODT) Excipient Product Introduction

1.2 Global Orally Dissolving Tablets (ODT) Excipient Market Size Forecast

1.2.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030)

1.2.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume (2019-2030)

1.2.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Price (2019-2030)

1.3 Orally Dissolving Tablets (ODT) Excipient Market Trends & Drivers

1.3.1 Orally Dissolving Tablets (ODT) Excipient Industry Trends

1.3.2 Orally Dissolving Tablets (ODT) Excipient Market Drivers & Opportunity

1.3.3 Orally Dissolving Tablets (ODT) Excipient Market Challenges

1.3.4 Orally Dissolving Tablets (ODT) Excipient Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Orally Dissolving Tablets (ODT) Excipient Players Revenue Ranking (2023)

2.2 Global Orally Dissolving Tablets (ODT) Excipient Revenue by Company (2019-2024)

2.3 Global Orally Dissolving Tablets (ODT) Excipient Players Sales Volume Ranking (2023)

2.4 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Company Players (2019-2024)

2.5 Global Orally Dissolving Tablets (ODT) Excipient Average Price by Company (2019-2024)

2.6 Key Manufacturers Orally Dissolving Tablets (ODT) Excipient Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Orally Dissolving Tablets (ODT) Excipient Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Orally Dissolving Tablets (ODT) Excipient

2.9 Orally Dissolving Tablets (ODT) Excipient Market Competitive Analysis

2.9.1 Orally Dissolving Tablets (ODT) Excipient Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Orally Dissolving Tablets (ODT) Excipient Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Dissolving Tablets (ODT) Excipient as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Binders

3.1.2 Glidents

3.1.3 Diluents

3.1.4 Disintegrants

3.1.5 Sweeteners

3.1.6 Others

3.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type

3.2.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Value, by Type (2019-2030)

3.2.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Value, by Type (%) (2019-2030)

3.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type

3.3.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume, by Type (2019-2030)

3.3.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume, by Type (%) (2019-2030)

3.4 Global Orally Dissolving Tablets (ODT) Excipient Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Anti-Psychotics Drug

4.1.2 Anti-Epileptics Drug

4.1.3 Others

4.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application

4.2.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Value, by Application (2019-2030)

4.2.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Value, by Application (%) (2019-2030)

4.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application

4.3.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume, by Application (2019-2030)

4.3.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume, by Application (%) (2019-2030)

4.4 Global Orally Dissolving Tablets (ODT) Excipient Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region

5.1.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2019-2024)

5.1.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2025-2030)

5.1.4 Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (%), (2019-2030)

5.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region

5.2.1 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2019-2024)

5.2.3 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2025-2030)

5.2.4 Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (%), (2019-2030)

5.3 Global Orally Dissolving Tablets (ODT) Excipient Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

5.4.2 North America Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

5.5.2 Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

5.6.2 Asia Pacific Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

5.7.2 South America Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

5.8.2 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value

6.2.1 Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.2.2 Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.3.2 United States Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.4.2 Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.5.2 China Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.5.3 China Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.6.2 Japan Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.7.2 South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.8.2 Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019-2030

6.9.2 India Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

6.9.3 India Orally Dissolving Tablets (ODT) Excipient Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 BASF

7.1.1 BASF Company Information

7.1.2 BASF Introduction and Business Overview

7.1.3 BASF Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.1.4 BASF Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.1.5 BASF Recent Development

7.2 JRS Pharma

7.2.1 JRS Pharma Company Information

7.2.2 JRS Pharma Introduction and Business Overview

7.2.3 JRS Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.2.4 JRS Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.2.5 JRS Pharma Recent Development

7.3 Roquette

7.3.1 Roquette Company Information

7.3.2 Roquette Introduction and Business Overview

7.3.3 Roquette Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Roquette Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.3.5 Roquette Recent Development

7.4 ABF Ingredients

7.4.1 ABF Ingredients Company Information

7.4.2 ABF Ingredients Introduction and Business Overview

7.4.3 ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.4.4 ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.4.5 ABF Ingredients Recent Development

7.5 DFE Pharma

7.5.1 DFE Pharma Company Information

7.5.2 DFE Pharma Introduction and Business Overview

7.5.3 DFE Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.5.4 DFE Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.5.5 DFE Pharma Recent Development

7.6 Evonik

7.6.1 Evonik Company Information

7.6.2 Evonik Introduction and Business Overview

7.6.3 Evonik Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Evonik Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.6.5 Evonik Recent Development

7.7 Merck KGaA

7.7.1 Merck KGaA Company Information

7.7.2 Merck KGaA Introduction and Business Overview

7.7.3 Merck KGaA Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Merck KGaA Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.7.5 Merck KGaA Recent Development

7.8 Ashland

7.8.1 Ashland Company Information

7.8.2 Ashland Introduction and Business Overview

7.8.3 Ashland Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Ashland Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.8.5 Ashland Recent Development

7.9 Meggle Pharma

7.9.1 Meggle Pharma Company Information

7.9.2 Meggle Pharma Introduction and Business Overview

7.9.3 Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.9.5 Meggle Pharma Recent Development

7.10 Shin-Etsu

7.10.1 Shin-Etsu Company Information

7.10.2 Shin-Etsu Introduction and Business Overview

7.10.3 Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.10.5 Shin-Etsu Recent Development

7.11 Fuji Chemical Industries

7.11.1 Fuji Chemical Industries Company Information

7.11.2 Fuji Chemical Industries Introduction and Business Overview

7.11.3 Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.11.5 Fuji Chemical Industries Recent Development

7.12 McePharma (Vivesa holding)

7.12.1 McePharma (Vivesa holding) Company Information

7.12.2 McePharma (Vivesa holding) Introduction and Business Overview

7.12.3 McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.12.4 McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.12.5 McePharma (Vivesa holding) Recent Development

7.13 Cargill Incorporated

7.13.1 Cargill Incorporated Company Information

7.13.2 Cargill Incorporated Introduction and Business Overview

7.13.3 Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.13.5 Cargill Incorporated Recent Development

7.14 Daicel Corporation

7.14.1 Daicel Corporation Company Information

7.14.2 Daicel Corporation Introduction and Business Overview

7.14.3 Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.14.5 Daicel Corporation Recent Development

7.15 Anhui Sunhere Pharmaceutical

7.15.1 Anhui Sunhere Pharmaceutical Company Information

7.15.2 Anhui Sunhere Pharmaceutical Introduction and Business Overview

7.15.3 Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Product Offerings

7.15.5 Anhui Sunhere Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Orally Dissolving Tablets (ODT) Excipient Industrial Chain

8.2 Orally Dissolving Tablets (ODT) Excipient Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Orally Dissolving Tablets (ODT) Excipient Sales Model

8.5.2 Sales Channel

8.5.3 Orally Dissolving Tablets (ODT) Excipient Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Fuji Chemical Industries

McePharma (Vivesa holding)

Cargill Incorporated

Daicel Corporation

Anhui Sunhere Pharmaceutical

List of Tables

Table 1. Orally Dissolving Tablets (ODT) Excipient Market Trends

Table 2. Orally Dissolving Tablets (ODT) Excipient Market Drivers & Opportunity

Table 3. Orally Dissolving Tablets (ODT) Excipient Market Challenges

Table 4. Orally Dissolving Tablets (ODT) Excipient Market Restraints

Table 5. Global Orally Dissolving Tablets (ODT) Excipient Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Orally Dissolving Tablets (ODT) Excipient Revenue Market Share by Company (2019-2024)

Table 7. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Orally Dissolving Tablets (ODT) Excipient Price by Company (2019-2024) & (US$/MT)

Table 10. Key Manufacturers Orally Dissolving Tablets (ODT) Excipient Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Orally Dissolving Tablets (ODT) Excipient Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Orally Dissolving Tablets (ODT) Excipient

Table 13. Global Orally Dissolving Tablets (ODT) Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Dissolving Tablets (ODT) Excipient as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Orally Dissolving Tablets (ODT) Excipient Price by Type (2019-2024) & (US$/MT)

Table 27. Global Orally Dissolving Tablets (ODT) Excipient Price by Type (2025-2030) & (US$/MT)

Table 28. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Orally Dissolving Tablets (ODT) Excipient Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Orally Dissolving Tablets (ODT) Excipient Price by Application (2019-2024) & (US$/MT)

Table 39. Global Orally Dissolving Tablets (ODT) Excipient Price by Application (2025-2030) & (US$/MT)

Table 40. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2019-2024) & (%)

Table 44. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Region (2025-2030) & (%)

Table 45. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2019-2024) & (%)

Table 49. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Region (2025-2030) & (%)

Table 50. Global Orally Dissolving Tablets (ODT) Excipient Average Price by Region (2019-2024) & (US$/MT)

Table 51. Global Orally Dissolving Tablets (ODT) Excipient Average Price by Region (2025-2030) & (US$/MT)

Table 52. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Volume, (2025-2030) & (K MT)

Table 57. BASF Company Information

Table 58. BASF Introduction and Business Overview

Table 59. BASF Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 60. BASF Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 61. BASF Recent Development

Table 62. JRS Pharma Company Information

Table 63. JRS Pharma Introduction and Business Overview

Table 64. JRS Pharma Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 65. JRS Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 66. JRS Pharma Recent Development

Table 67. Roquette Company Information

Table 68. Roquette Introduction and Business Overview

Table 69. Roquette Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 70. Roquette Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 71. Roquette Recent Development

Table 72. ABF Ingredients Company Information

Table 73. ABF Ingredients Introduction and Business Overview

Table 74. ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 75. ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 76. ABF Ingredients Recent Development

Table 77. DFE Pharma Company Information

Table 78. DFE Pharma Introduction and Business Overview

Table 79. DFE Pharma Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 80. DFE Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 81. DFE Pharma Recent Development

Table 82. Evonik Company Information

Table 83. Evonik Introduction and Business Overview

Table 84. Evonik Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 85. Evonik Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 86. Evonik Recent Development

Table 87. Merck KGaA Company Information

Table 88. Merck KGaA Introduction and Business Overview

Table 89. Merck KGaA Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 90. Merck KGaA Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 91. Merck KGaA Recent Development

Table 92. Ashland Company Information

Table 93. Ashland Introduction and Business Overview

Table 94. Ashland Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 95. Ashland Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 96. Ashland Recent Development

Table 97. Meggle Pharma Company Information

Table 98. Meggle Pharma Introduction and Business Overview

Table 99. Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 100. Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 101. Meggle Pharma Recent Development

Table 102. Shin-Etsu Company Information

Table 103. Shin-Etsu Introduction and Business Overview

Table 104. Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 105. Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 106. Shin-Etsu Recent Development

Table 107. Fuji Chemical Industries Company Information

Table 108. Fuji Chemical Industries Introduction and Business Overview

Table 109. Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 110. Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 111. Fuji Chemical Industries Recent Development

Table 112. McePharma (Vivesa holding) Company Information

Table 113. McePharma (Vivesa holding) Introduction and Business Overview

Table 114. McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 115. McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 116. McePharma (Vivesa holding) Recent Development

Table 117. Cargill Incorporated Company Information

Table 118. Cargill Incorporated Introduction and Business Overview

Table 119. Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 120. Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 121. Cargill Incorporated Recent Development

Table 122. Daicel Corporation Company Information

Table 123. Daicel Corporation Introduction and Business Overview

Table 124. Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 125. Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 126. Daicel Corporation Recent Development

Table 127. Anhui Sunhere Pharmaceutical Company Information

Table 128. Anhui Sunhere Pharmaceutical Introduction and Business Overview

Table 129. Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 130. Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Product Offerings

Table 131. Anhui Sunhere Pharmaceutical Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Orally Dissolving Tablets (ODT) Excipient Downstream Customers

Table 135. Orally Dissolving Tablets (ODT) Excipient Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Orally Dissolving Tablets (ODT) Excipient Product Picture

Figure 2. Global Orally Dissolving Tablets (ODT) Excipient Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume (2019-2030) & (K MT)

Figure 5. Global Orally Dissolving Tablets (ODT) Excipient Sales Price (2019-2030) & (US$/MT)

Figure 6. Orally Dissolving Tablets (ODT) Excipient Report Years Considered

Figure 7. Global Orally Dissolving Tablets (ODT) Excipient Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Orally Dissolving Tablets (ODT) Excipient Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Orally Dissolving Tablets (ODT) Excipient Revenue in 2023

Figure 10. Orally Dissolving Tablets (ODT) Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Binders Picture

Figure 12. Glidents Picture

Figure 13. Diluents Picture

Figure 14. Disintegrants Picture

Figure 15. Sweeteners Picture

Figure 16. Others Picture

Figure 17. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Orally Dissolving Tablets (ODT) Excipient Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 20. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Orally Dissolving Tablets (ODT) Excipient Price by Type (2019-2030) & (US$/MT)

Figure 22. Product Picture of Anti-Psychotics Drug

Figure 23. Product Picture of Anti-Epileptics Drug

Figure 24. Product Picture of Others

Figure 25. Global Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Orally Dissolving Tablets (ODT) Excipient Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 28. Global Orally Dissolving Tablets (ODT) Excipient Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Orally Dissolving Tablets (ODT) Excipient Price by Application (2019-2030) & (US$/MT)

Figure 30. North America Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Orally Dissolving Tablets (ODT) Excipient Sales Volume (%), (2019-2030)

Figure 42. United States Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 48. China Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 50. China Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 60. India Orally Dissolving Tablets (ODT) Excipient Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Orally Dissolving Tablets (ODT) Excipient Sales Value by Type (%), 2023 VS 2030

Figure 62. India Orally Dissolving Tablets (ODT) Excipient Sales Value by Application (%), 2023 VS 2030

Figure 63. Orally Dissolving Tablets (ODT) Excipient Industrial Chain

Figure 64. Orally Dissolving Tablets (ODT) Excipient Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions